Myxoid/round cell liposarcoma
Clinical trials for Myxoid/round cell liposarcoma explained in plain language.
Never miss a new study
Get alerted when new Myxoid/round cell liposarcoma trials appear
Sign up with your email to follow new studies for Myxoid/round cell liposarcoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug shrink advanced solid tumors?
Disease control Recruiting nowThis trial tests an experimental drug called DS-2243a in adults with advanced solid tumors, including sarcoma, that have spread or cannot be removed surgically. The study has two parts: first, researchers find the safest dose by giving increasing amounts to small groups; then, th…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase 1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Experimental drug aims to revive failing cancer fighters in rare sarcomas
Disease control Recruiting nowThis early-phase trial tests an immunotherapy drug called N-803 in up to 8 people with synovial sarcoma or myxoid/round cell liposarcoma whose cancer got worse after a prior cell therapy. N-803 is designed to boost the patient's own immune cells that survived the earlier treatmen…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Early phase 1 • Sponsor: Seth Pollack • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Genetically modified NK cells take on rare sarcomas in early trial
Disease control Recruiting nowThis early-phase trial tests a new therapy for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Participants receive donated natural killer (NK) cells that have been engineered to recognize and attack a protein called NY-ESO-1 found on their cancer cells. T…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC